↓ Skip to main content

Cochrane Database of Systematic Reviews

Second-generation antipsychotics for major depressive disorder and dysthymia

Overview of attention for article published in Cochrane database of systematic reviews, December 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
2 policy sources
twitter
5 tweeters
wikipedia
20 Wikipedia pages
video
1 video uploader

Citations

dimensions_citation
137 Dimensions

Readers on

mendeley
286 Mendeley
connotea
1 Connotea
Title
Second-generation antipsychotics for major depressive disorder and dysthymia
Published in
Cochrane database of systematic reviews, December 2010
DOI 10.1002/14651858.cd008121.pub2
Pubmed ID
Authors

Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling, Stefan Leucht

Abstract

Major depressive disorder (MDD) is a common condition with a lifetime prevalence of 15% to 18%, which leads to considerable suffering and disability. Some antipsychotics have been reported to induce remission in major depression, when added to an antidepressant.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 286 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 <1%
Netherlands 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 278 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 48 17%
Student > Master 40 14%
Student > Ph. D. Student 28 10%
Student > Doctoral Student 27 9%
Other 23 8%
Other 75 26%
Unknown 45 16%
Readers by discipline Count As %
Medicine and Dentistry 115 40%
Psychology 32 11%
Pharmacology, Toxicology and Pharmaceutical Science 25 9%
Nursing and Health Professions 16 6%
Agricultural and Biological Sciences 8 3%
Other 36 13%
Unknown 54 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2022.
All research outputs
#1,009,254
of 21,235,767 outputs
Outputs from Cochrane database of systematic reviews
#2,386
of 12,096 outputs
Outputs of similar age
#5,450
of 139,912 outputs
Outputs of similar age from Cochrane database of systematic reviews
#6
of 103 outputs
Altmetric has tracked 21,235,767 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,096 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,912 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.